Clinical Trials
56 trialsTRAP-PAIN
Kayseri Education and Research Hospital
CHLOECAPA
Institut National de la Santé Et de la Recherche Médicale, France
PRO-MIND
Ankara Etlik City Hospital
Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
Tel-Aviv Sourasky Medical Center
Turkish Version of the UCLA Prostate Cancer Index
Lokman Hekim University
PRINToUT
NHS Lothian
Lymphedema After Urologic Surgery
Vastra Gotaland Region
BLUSH
Vastra Gotaland Region
CaRe
Linkoeping University
RI-NIVO
Azienda USL Reggio Emilia - IRCCS
ARPC-MRI
East and North Hertfordshire NHS Trust
SPRINTR-REAL
Region Västerbotten
Primary Prostatic Lymphoma on a 66 Year-old Male in Mexico.
Instituto Mexicano del Seguro Social
PSMA-RADS
Zagazig University
KEEPER
Azienda USL Reggio Emilia - IRCCS
PCa_LS
Azienda USL Reggio Emilia - IRCCS
IEPBR
Ankara Etlik City Hospital
In Vivo Dosimetry for Brachytherapy Study
East and North Hertfordshire NHS Trust
A Diagnostic Prediction Model for Prostate Cancer in Patients With PI-RADS Score 3
Anhui Provincial Hospital
5TbpMRI
Anhui Provincial Hospital
The Addictive Diagnostic Value of Apparent Diffusion Coefficients to bpMRI in the Diagnosis of Prostate Cancer
Anhui Provincial Hospital
NOCATIN
Jahn Ferenc South Pest Teaching Hospital
Pathological Positivity Rate in Prostate Cancer Patients with PI-RADS 4 and First Negative Biopsy
Anhui Provincial Hospital
IMNR
Dr. Lutfi Kirdar Kartal Training and Research Hospital
The Impact of Neoadjuvant Chemotherapy on Survival Outcomes in Patients With Variant Histologies Bladder Cancer Who Underwent Radical Cystectomy
Ankara Etlik City Hospital
ASWBP
Anhui Provincial Hospital
PROMIC
Turku University Hospital
Risk-adapted Strategy Including Magnetic Resonance Imaging and Prostate-specific Antigen Density in Blood for Biopsy Decision in Patients With Lesions Suspicious for Prostate Cancer
Ankara Etlik City Hospital
Quality of Life and Shared Decision Making in Prostate Cancer
Norwegian Institute of Public Health
The Effect of Frailty on Blood Biology Indicators, Quality of Life and Survival of Patients With Radical Prostatectomy
Anhui Provincial Hospital
PSA2STHLM3/1
Helse Stavanger HF
Protein Kinase A in Prostate Cancer Tissue.
Ziv Hospital
Genital Lichen Sclerosus - Epidemiology, Comorbidities and the Role of Vulvar and Penile Microbiome
Region Jönköping County
Personalized Urine Biomarker for Patients With Bladder Cancer
Ziv Hospital
Detection of FGFR Gene Mutations in the Tumor Tissue and Urine of Patients With Urothelial Carcinoma
National Cancer Center, Korea
High-power Green-light Laser Endoscopic Submucosal Dissection for Non-muscle-invasive Bladder Cancer
Shandong Provincial Hospital
Smurf2 Gene Expression in Urinary Tract Tumors
Ziv Hospital
NorCys-NLR
Turku University Hospital
NorCys-Alb
Turku University Hospital
NorCys-Transf
Turku University Hospital
Fertility After Prostate Brachytherapy
East and North Hertfordshire NHS Trust
TransTuFo
Hull University Teaching Hospitals NHS Trust
UroX Biomarker Bladder Cancer Study
East and North Hertfordshire NHS Trust
Zinc/PSA Ratio as a Novel Biomarker for Prostate Cancer Detection
Bagcilar Training and Research Hospital
Does End-fire Technique Increase Detection Rate of Prostate Cancer at First Re-biopsy Compared to Side-fire Technique?
Kronoberg County Council
Pain Comparison Whit Visual Analog Scale (EVA) Between Four Analgesic Methods During Trans Rectal Prostatic Biopsy
Instituto Mexicano del Seguro Social
Character Traits and Stress in Suspected Prostate Cancer
Helse Stavanger HF
PROFUGO
Barwon Health
PROAG
Turku University Hospital
Deformable Registration of Multi-parametric MRI to Intra-operative Transrectal Ultrasound for Prostate Brachytherapy
Sheba Medical Center